Home Top News It’s Pharma Time: Why Merck and Lilly Are Buys, but Not Pfizer. Top News It’s Pharma Time: Why Merck and Lilly Are Buys, but Not Pfizer. By - January 7, 2023 0 11 Facebook Twitter Pinterest WhatsApp [#item_full_content] RELATED ARTICLESMORE FROM AUTHOR 2 “Strong Buy” Penny Stocks That Could Rally All the Way to $11 (or More) 15 dividend stocks whose 5% to 10% yields appear safe in 2023 and 2024 by this analysis Cathie Wood’s Investment Firm has Bought These 3 Stocks at Least 7 Days In a Row LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. Good News For FTX Customers: The Bahamas Seized $3.5 billion in... Bitcoin close to wipeout territory Berkshire Hathaway Cuts Stake in U.S. Bancorp By More Than Half.... 4 Signs It’s Time to Fire Your Financial Advisor 5 Best Chinese Stocks To Buy And Watch: Covid Lockdowns In...
